跳至主要内容
临床试验/EUCTR2012-001766-15-ES
EUCTR2012-001766-15-ES进行中(未招募)不适用

Impact of azithromycin as an immunomodulator in patients with recurrent pneumonia and deficit of mannose-binding LECITHIN (MBL2012) - The role of azithromycin in the MBL deficiency

Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla0 个研究点开始时间: 2012年8月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • A. - Patient greater than six months and less than 14 years.
  • 2. - Patients with NR, ie, at least two pneumonic episodes observed radiologically in an interval of one year or three episodes at any time in his life, whenever there is radiological normalization between episodes.
  • 3. - Patient with MBL deficiency, ie serum MBL levels <500 ng / ml.
  • 4. - Patients whose parents or guardians accept their participation in the study by signing an informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 40
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. - Patients with other associated immunodeficiencies.
  • 2. - Patients with other lung diseases, heart disease or cancer processes.
  • 3. - Patients with allergies to azitromicine, other macrolides or any excipients of the formulation.
  • 4. - Patients treated with other drugs that may interact with macrolides.
  • 5. - Patients with long QT for age.

研究者

发起方
Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla

相似试验